As of Feb 23
| +0.10 / +1.43%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 23.50, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +230.99% increase from the last price of 7.10.
The current consensus among 6 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.